Amanta Healthcare shareholders approve MD remuneration revision at 31st AGM

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Amanta Healthcare held its 31st AGM on September 16, 2026, via video conferencing
  • Shareholders approved the adoption of financial statements for the fiscal year ending March 31, 2026
  • A special resolution was passed to revise the remuneration of Managing Director Bhavesh Girishbhai Patel
  • Nimesh P Patel was reappointed as a director liable to retire by rotation
  • Kashyap R. Mehta & Partners were appointed as Secretarial Auditors for five years
powered bylight_fuzz_icon
51102641

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare Limited held its 31st Annual General Meeting on September 16, 2026, via video conferencing. The assembly approved the adoption of financial statements for FY26 and passed a special resolution to revise the Managing Director’s remuneration.

The meeting commenced at 12:09 pm and concluded at 12:48 pm, including time allocated for e-voting. Chairman Bhavesh Girishbhai Patel confirmed the presence of the requisite quorum and declared the meeting in order. All directors and key managerial personnel attended the session from their respective locations.

Key Resolutions Passed

Shareholders voted on five agenda items during the proceedings. Four ordinary resolutions were approved, covering the adoption of financial statements, director reappointment, secretarial auditor appointment, and cost auditor remuneration ratification. One special resolution addressed executive compensation.

Resolution Type Agenda Item Status
Ordinary Adoption of Financial Statements for FY26 Passed
Ordinary Appointment of Nimesh P Patel as director Passed
Ordinary Appointment of Kashyap R. Mehta & Partners as Secretarial Auditors Passed
Ordinary Ratification of cost auditor remuneration for FY27 Passed
Special Revision in remuneration payable to Bhavesh Girishbhai Patel Passed

Governance and Compliance

Nimesh P Patel was reappointed as a director liable to retire by rotation. The company also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for a term of five consecutive years. The remuneration of the cost auditor for the financial year 2026-27 was ratified by the members.

Statutory Auditors Price Waterhouse Chartered Accountants LLP and Secretarial Auditors Kashyap R. Mehta & Partners attended the meeting. The Company Secretary reported no qualifications, observations, or adverse remarks in either the Statutory Auditor’s Report or the Secretarial Auditor’s Report.

Participation Details

A total of 34 members participated in the virtual meeting. Registered speakers raised queries, which were addressed by the Chairman. Voting continued for 15 minutes post-proceedings to allow additional member participation via the CDSL platform. Nikhita Dinodia, Company Secretary and Compliance Officer, was authorized to declare the voting results.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.00%-5.91%+21.49%+98.40%+38.64%+33.99%

How will the revised remuneration structure for Managing Director Bhavesh Girishbhai Patel influence executive retention and long-term strategic alignment?

What specific growth initiatives or operational changes does Amanta Healthcare plan to undertake in FY27 given the clean audit reports and approved financials?

How might the five-year appointment of Kashyap R. Mehta & Partners as Secretarial Auditors impact the company's governance transparency and compliance standards?

Amanta Healthcare begins manufacturing at new Steriport facility in Kheda

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Amanta Healthcare has commenced manufacturing at its new Steriport facility
  • The facility is located at the company's Kheda campus
  • The development marks an operational milestone in the company's manufacturing expansion
powered bylight_fuzz_icon
49898320

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare has commenced manufacturing operations at its new Steriport facility, located at its Kheda campus.

Facility launch details

The commencement of manufacturing at the Steriport facility marks an operational milestone for Amanta Healthcare at its Kheda campus. The Steriport facility represents an addition to the company's existing manufacturing infrastructure at the site.

Parameter Details
Company Amanta Healthcare
Development Commencement of manufacturing
Facility Steriport facility
Location Kheda campus

The launch of manufacturing activity at the Kheda-based Steriport facility signals an expansion of Amanta Healthcare's production capabilities at this location.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.00%-5.91%+21.49%+98.40%+38.64%+33.99%

How will the increased production capacity at the Kheda campus impact Amanta Healthcare's revenue projections for the upcoming fiscal year?

Does the Steriport facility focus on specific high-margin product lines, and how does this align with current market demand trends?

What is the expected timeline for the facility to reach full operational capacity, and what are the associated capital expenditure implications?

More News on Amanta Healthcare

1 Year Returns:+38.64%